Horowitz Group

Vibrato Medical is creating a noninvasive treatment for Critical Limb Ischemia and Peripheral Arterial Disease in order to increase tissue perfusion, alleviate symptoms, and save limbs. Based on decades of study and the most recent advances in ultrasound technology, our gadget is the first wearable therapeutic ultrasound designed to stimulate vasodilation and vessel development.

Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.

Metavention develops new treatment that is intended to permanently disrupt the overactive nerves that cause high blood pressure and other metabolic diseases. They offer a renal denervation procedure that delivers radio frequency energy to targeted overactive sympathetic nerves using their IRF denervation system.

Miniluxe operates as a nail and beauty lounge that offers manicures, pedicures, warm oil treatment, waxing, and hands and feet therapies. It was founded in 2006 and is headquartered in Boston, Massachusetts.